However, mutation of either Keap1 and NRF2 in RCC is a very rare event (Supplemental Table S2) and the mutant cohorts were too small to form meaningful evaluation of the role of their mutations in RCC. This evidence concerns the gene NFE2L2 and renal cell carcinoma.